Login

Sandro Tobler, VP of Fiber Optic Technology and Operations, shares his experience working at HUBER+SUHNER. 00:10:00

Share On Facebook Share On Twitter

Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Evolution and Growth of America's Welfare State: From the New Deal to the Great Society|William Voegeli
00:10:00
The Importance of a Goals-Based Exit Plan for Your Business | John D. Weninger, CFP at Endowment Wealth Management, Inc.
00:00:00
Neurologist and psychiatrist / Alice Weaver Flaherty, M.D., Ph.D.
00:10:00
Highfield Resources Ltd CEO Ignacio Salazar reaffirms outstanding feasibility study results, secures financing, and outlines strategic steps amidst volatile potash market.|Ignacio Salazar CEO of Highfield Resources
00:10:00
Mats Karlsson Landré and I discuss data diodes and OT. | Marie Bengtsson, CEO, Advenica AB (publ) ADVE:STO
00:10:00
A former spacecraft engineer revolutionises the energy management industry with a breakthrough project in Anacle Systems|CEO , Anacle Systems Ltd
00:10:00
Eldridge Industries' Todd Boehly Discusses New Ventures in Asset Management and Credit Outlook | Todd Boehly - Co-Founder, Chairman & CEO of Eldridge Industries
00:10:00
new industries and profoundly influenced productivity, creativity, and the global economy|Casey Aylward,Partner,Accel
00:10:00
Strategic Vision: Dato Isaac Lugun on Corporate Leadership at Cahya Mata Sarawak Berhad
00:10:00
Starting a Career in Real Estate at Blackstone
00:10:00
Susan Davy, CFO of Pennon Group, discusses the impact of environmental and social risks on stakeholder relationships.
00:10:00
"Global ETF Portfolio Strategy: Kevin Vandermeer, CFA, on Market Commentary and Tactical Positioning with Townshend, Somani, and Hunter Group"

© 2017 - Neuhu+